u/EmptyCash5704 · 65d agono track record yet
“41K bet (image reference)”
41K bet on DXCM turnaround play
CGM technology mainstream adoption, revenue growth acceleration, margin expansion, Stelo product success, and type 2 diabetes coverage expansion will drive a revaluation away from depressed medical device valuation.
At post $71.90Now $71.54-0.5% since postedas of Jul 24, 4:59 PM ET
1d+0.3%
3d+0.3%
1w+0.6%
1m+0.8%
3m—
6m—
1y—